Visible Genetics Reaffirms Q1 Forecast

Apr 08, 2002

NEW YORK, April 8 - Visible Genetics today reaffirmed its first-quarter earnings projections, saying total revenue will come in between $4.2 million and $4.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Cholesterol-Regulating Gene Variant Found to Affect Bacterial Infection Susceptibility
Genomic Analysis of Wilms Tumors Leads to Kidney Development-Related Pathways
TJU-Led Team Wins $2.7M NCI Grant to Study Circulating Tumor Cells in Breast Cancer
New Zealand Commits NZ$35M to Genomics Research
Top Five Articles on GenomeWeb Last Week: Early Cancers, ASCO, Circulating Tumor Cells, and More
Genesis Healthcare Raises ¥1.5B in Stock Placement

The Scan

Like Sears, But With Cells

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Infertile Mouse No More

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

PGD Growth Spurt

China is embracing preimplantation genetic diagnosis, Nature News reports.

This Week in PLOS

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Main menu